October 26, 2015
FDA panel recommends AZ gout drug for approval; Valeant to form committee to examine specialty pharmacy ties; patients treated with Keytruda had longer survival than those who took chemo
- Is the Trump Administration the Cure the FDA Needs?
- Five things for pharma marketers to know: Friday, February 24, 2017
- MAHF honors Abbate and Lazur, Future Famers
- Five things for pharma marketers to know: Thursday, February 23, 2017
- Almost one-third of programmatic ads violate IAB guidelines, study finds